Cat.#: ACPP-1345
| Despition | DISC1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1649 | Human EFNA5 Protein (AC1649) | 2 µg | inquiry |
| ACPP-1746 | Human Acrp30 Protein (AC1746) | 10 µg | inquiry |
| ACPP-1316 | GPCR GPR7 Blocking Peptide (AC1316) | 250 µg | inquiry |
| ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
| ACPP-1546 | Human HNMT Protein (AC1546) | 5 µg | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1129 | Recombinant Human GLP-1R Protein (Fc Tag) (AC1129) | 50 µg | inquiry |
| ACPP-1357 | P2Y12 Blocking Peptide (AC1357) | 250 µg | inquiry |
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1094 | Recombinant Human FGFR4 Protein (Functional) (AC1094) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.